FULL CITATION RECORD
Selank References: The Full Citation Record
Twenty-one indexed peer-reviewed citations. Each links to PubMed, a DOI, or the journal of record.
The citation record at a glance
The Selank references list is twenty-one peer-reviewed citations long and skews heavily Russian. Bulletin of Experimental Biology and Medicine carries seven of them. Eksperimental'naia i Klinicheskaia Farmakologiia carries five. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova carries two — including the principal controlled human trial, Zozulia et al. (2008), and the parallel immunomodulatory paper, Uchakina et al. (2008). The non-Russian English-language record consists of Frontiers in Pharmacology, Behavioural Neurology, Doklady Biological Sciences, Neuroscience and Behavioral Physiology, and Voprosy Virusologii.
That distribution is itself the headline. Selank's evidence base is real, indexed, and reproducible across multiple authors at multiple Russian institutes — and it is not a literature with substantial independent non-Russian replication. We surface that geography rather than smooth it over.
-
[01]
Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova. 2008.
-
[02]
Zolotarev YA, Dadayan AK, Bocharov EV, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bulletin of Experimental Biology and Medicine. 2001.
-
[03]
Kolik LG, Kolyasnikova KN, Vasileva EV, et al. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions. Bulletin of Experimental Biology and Medicine. 2002.
-
[04]
Inozemtseva LS, Karpenko EA, Dolotov OV, et al. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo. Doklady Biological Sciences. 2008.
PMID 18841804 · DOI 10.1134/S0012496608040066
-
[05]
Volkova A, Shadrina M, Kolomin T, et al. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats. Bulletin of Experimental Biology and Medicine. 2019.
PMID 31625062 · DOI 10.1007/s10517-019-04588-9
-
[06]
Filatova E, Kasian A, Kolomin T, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology. 2017.
· DOI 10.3389/fphar.2017.00089
-
[07]
Kasian A, Kolomin T, Andreeva L, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behavioural Neurology. 2017.
· DOI 10.1155/2017/5091027
-
[08]
Semenova TP, Kozlovskaia MM, Zuikov AV, et al. Comparison of the effects of selank and tuftsin on the metabolism of serotonin in the brain of rats pretreated with PCPA. Eksperimental'naia i Klinicheskaia Farmakologiia. 2009.
-
[09]
Semenova TP, Kozlovskaia MM, Zuikov AV, et al. Effects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB/C and C57Bl/6 mice: a comparative study. Eksperimental'naia i Klinicheskaia Farmakologiia. 2008.
-
[10]
Uchakina ON, Uchakin PN, Miasoedov NF, et al. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova. 2008.
-
[11]
Mezentseva MV, Stakhanov VA, Zacharova IA, et al. Antiviral activity of immunomodulator Selank in experimental influenza infection. Voprosy Virusologii. 2009.
-
[12]
Kolik LG, Konstantinopolsky MA. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats. Bulletin of Experimental Biology and Medicine. 2022.
PMID 36322304 · DOI 10.1007/s10517-022-05624-x
-
[13]
Kolik LG, Nadorova AV, Kozlovskaya MM. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Eksperimental'naia i Klinicheskaia Farmakologiia. 2014.
-
[14]
Kolik LG, Nadorova AV, Antipova TA, et al. Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice. Bulletin of Experimental Biology and Medicine. 2016.
-
[15]
Semenova TP, Kozlovskaia MM, Zuikov AV, et al. Compensatory effect of selank on the mnestic functions disturbed by neurotoxic damage of the noradrenergic system of the rat brain. Eksperimental'naia i Klinicheskaia Farmakologiia. 2008.
-
[16]
Semenova TP, Kozlovskaya MM, Zuikov AV, et al. Protective effect of selank on the model of mnestic function violation induced by pharmacological blockade of protein synthesis. Eksperimental'naia i Klinicheskaia Farmakologiia. 2014.
-
[17]
Semenova TP, Kozlovskaia MM, Zuikov AV, et al. Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice. Eksperimental'naia i Klinicheskaia Farmakologiia. 2008.
-
[18]
Semenova TP, Kozlovskaya MM, Zuikov AV, et al. Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia. Neuroscience and Behavioral Physiology. 2007.
-
[19]
Andreeva LA, Nagaev IY, Mezentseva MV, et al. Selank and its metabolites maintain homeostasis in the gastric mucosa. Bulletin of Experimental Biology and Medicine. 2007.
-
[20]
Lobov GI, Kubasov RV. Effect of new synthetic anxiolytic selank on gastric wall blood flow and mesenteryc lymphatic vessels contractility in anesthetized rats. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova. 2005.
-
[21]
Kozlovskaia MM, Kozlovskii II, Vald'man EA, et al. Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system. Bulletin of Experimental Biology and Medicine. 2006.